Bailard Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPDR Gold Trust
GLD
|
+$62.8M |
| 2 |
PIMCO Intermediate Municipal Bond Active Exchange-Traded Fund
MUNI
|
+$41M |
| 3 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$22.2M |
| 4 |
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
|
+$17.5M |
| 5 |
iShares iBonds Dec 2026 Term Treasury ETF
IBTG
|
+$13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
|
+$61.4M |
| 2 |
iShares California Muni Bond ETF
CMF
|
+$37.9M |
| 3 |
IBTE
iShares iBonds Dec 2024 Term Treasury ETF
IBTE
|
+$29.8M |
| 4 |
iShares National Muni Bond ETF
MUB
|
+$12.4M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$8.52M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.41% |
| 2 | Healthcare | 8.75% |
| 3 | Financials | 6.76% |
| 4 | Consumer Discretionary | 4.63% |
| 5 | Communication Services | 4.52% |
Similar funds
Bailard's Q4 2023 Portfolio in Review
As of Q4 2023, Bailard held 841 positions worth $3.38B, up 12% from $3.02B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Bailard's Q4 2023 filing shows 147 new, 207 increased, 242 reduced and 138 closed positions. Its largest new stake was Vanguard Tax-Exempt Bond Index Fund: 452,690 shares worth $23.1M. The largest sale was Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF, an estimated $61.4M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- Bailard's largest Q4 2023 buy was Vanguard Tax-Exempt Bond Index Fund: 452,690 shares worth $23.1M.
- Bailard added most to SPDR Gold Trust in Q4 2023, an estimated $62.8M increase.
- Bailard's biggest Q4 2023 reduction was Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF, cutting an estimated $61.4M.
- Bailard fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $5.5M.
- Bailard's ten largest holdings make up 29% of its $3.38B portfolio in Q4 2023.
- Bailard opened 147 new positions and closed 138 in Q4 2023.
- Bailard's portfolio value rose 12% quarter-over-quarter to $3.38B.
Based on Bailard's 13F filing for Q4 2023, filed 2 Feb 2024.